HomePSTV • NASDAQ
add
Plus Therapeutics Inc
Previous close
$0.75
Day range
$0.62 - $0.77
Year range
$0.24 - $2.67
Market cap
10.87M USD
Avg Volume
32.77M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.41M | 7.54% |
Operating expense | 3.13M | 31.51% |
Net income | -3.90M | -2.44% |
Net profit margin | -276.42 | 4.74% |
Earnings per share | -0.49 | 30.00% |
EBITDA | -3.70M | 0.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.61M | -57.84% |
Total assets | 6.63M | -41.75% |
Total liabilities | 15.58M | 22.35% |
Total equity | -8.95M | — |
Shares outstanding | 17.00M | — |
Price to book | -0.49 | — |
Return on assets | -143.27% | — |
Return on capital | 265.09% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.90M | -2.44% |
Cash from operations | -1.21M | 35.62% |
Cash from investing | 64.00K | 252.38% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -1.15M | 53.22% |
Free cash flow | 168.50K | 107.02% |
About
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, United States. Wikipedia
Founded
1996
Headquarters
Website
Employees
21
